GlassScriptPhysician profile
Lisa Price
NPI 1962882787
$848.21
in general payments reported to CMS, 2019-2025
19 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2022: $133 · 2023: $258 · 2024: $186 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $181.89 | 2021-2024 | |
| Astellas Pharma US INC | $138.28 | 2023-2025 | Veozah |
| Millicent US INC | $82.18 | 2023-2024 | Intrarosa, Femring |
| Novo Nordisk INC | $63.22 | 2022-2023 | Rybelsus, Ozempic |
| Mayne Pharma Commercial LLC | $40.12 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $38.96 | 2022-2023 | Farxiga |
| Organon LLC | $36.02 | 2023-2024 | Nexplanon |
| Pfizer INC. | $35.80 | 2023 | |
| Exact Sciences Corporation | $34.87 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $30.38 | 2022 | |
| Exeltis, USA INC. | $28.86 | 2023-2025 | Slynd |
| Hologic Sales and Service, LLC | $23.91 | 2025 | Aptima |
| Idorsia Pharmaceuticals US INC | $19.94 | 2023 | Quviviq |
| Ascend Therapeutics US, LLC | $17.93 | 2023 | |
| Lilly USA, LLC | $17.05 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.37 | 2023 | Prolia, Evenity |
| Acella Pharmaceuticals, LLC | $15.34 | 2024 | NP Thyroid 60 |
| Acerus Pharmaceuticals Corporation | $14.79 | 2022 | |
| Medtronic, INC. | $13.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.